Log in
Enquire now
Optina Diagnostics

Optina Diagnostics

Optina Diagnostics develops technology for the early detection of disease through the eye.

OverviewStructured DataIssuesContributors
Is a
Company
Company
Organization
Organization
AngelList URL
angel.co/optina-diagnostics
CEO
‌
David Lapointe
0
Company Operating Status
Active
Crunchbase URL
crunchbase.com/organiz...gnostics
Facebook URL
@Optina-Diagnostics-Inc-1058244117632324
Industry
‌
Neurodegenerative Disease
Neuroscience
Neuroscience
Alzheimer's disease
Alzheimer's disease
Artificial Intelligence (AI)
Artificial Intelligence (AI)
Investors
Desjardins Venture Capital
Desjardins Venture Capital
Zoic Capital
Zoic Capital
William Guttman
William Guttman
Advisors.Fund
Advisors.Fund
Pallasite Ventures
Pallasite Ventures
DigitalDx Ventures
DigitalDx Ventures
Hike Ventures
Hike Ventures
Barney Pell (entrepreneur)
Barney Pell (entrepreneur)
Boehringer Ingelheim Venture Fund
Boehringer Ingelheim Venture Fund
Creative Destruction Lab
Creative Destruction Lab
•••
Latest Funding Round Date
October 28, 2021
Latest Funding Round Amount (USD)
20,100,000
Latest Funding Type
Series A
Series A
LinkedIn URL
@company/optina-diagnostics
Location
Canada
Canada
Patents Assigned (Count)
1
Pitchbook URL
pitchbook.com/profiles...163580-68
Spun Out From
Photon etc.
Photon etc.
Total Funding Amount (USD)
24,100,000
Twitter URL
@Optinadx
Official Website
optinadx.com
Wellfound ID
optina-diagnostics

Find more companies like Optina Diagnostics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.